Editas Medicine and AskBio enter strategic research collaboration
Editas and Asklepios announced a research collaboration to explore in vivo delivery of genome editing medicines to treat neurological diseases. This collaboration brings together AskBio’s capsid development, clinical stage AAV vector delivery system with Editas' genome editing technologies. October 15, 2019